Plavix Could Face Rival Prasugrel In Second Half
This article was originally published in The Pink Sheet Daily
Executive Summary
Combined Lilly/Daiichi sales force stands ready to support antiplatelet drug’s launch when approval comes, Lilly head of cardiovascular research tells “The Pink Sheet” DAILY.